Literature DB >> 32841741

Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study.

Zeyuan Qiang1, Wenhua Zhang2, Shuai Jin3, Kunfu Dai1, Yuting He3, Lianyuan Tao1, Haibo Yu4.   

Abstract

INTRODUCTION AND
OBJECTIVE: The purpose of this study was to investigate the expression levels and prognostic roles of α-fetoprotein (AFP), carcinoembryonic antigen (CEA), and Ki67 in tumor tissues of intrahepatic cholangiocarcinoma (ICC) patients. PATIENTS OR
MATERIALS AND METHODS: The study involved ninety-two ICC patients with complete clinicopathological data and follow-up information, who had previously undergone radical surgery. AFP, CEA, CD10, CD34, and Ki67 were detected in tumor tissues using immunohistochemistry. Statistical tests were used to identify independent risk factors and their associations with overall survival (OS) and disease-free survival (DFS).
RESULTS: AFP, CEA and Ki67 were strongly correlated with prognosis. Univariate analysis indicated that higher AFP (P = 0.002), CEA (P < 0.0001), Ki67 (P < 0.0001), CA19-9 (P = 0.039), and CA12-5 (P = 0.002), and larger tumor size (P = 0.001), as well as more advanced tumor node metastasis (TNM) staging (P < 0.0001) were all associated with worse OS. Meanwhile, higher AFP (P = 0.002), CEA (P = 0.001), and Ki67 (P < 0.0001), as well as more advanced TNM staging (P = 0.005) were associated with worse DFS. Multivariate analysis showed that higher AFP (HR = 2.004, 95%CI: 1.146-3.504 P = 0.015), CEA (HR = 2.226, 95%CI: 1.283-3.861 P = 0.004), and Ki67 (HR = 3.785, 95%CI: 2.073-6.909 P < 0.0001), as well as more advanced TNM staging (HR = 2.900, 95%CI: 1.498-5.757 P = 0.002) had associations with worse OS. Furthermore, higher AFP (HR = 2.172, 95%Cl: 1.291-3.654 P = 0.003), CEA (HR = 1.934, 95%Cl: 1.180-3.169 P = 0.009), and Ki67 (HR = 2.203, 95%Cl: 1.291-3.761 P = 0.004) had associations with worse DFS.
CONCLUSION: High AFP, CEA, and Ki67 are significant prognostic indicators in ICC patients, and can be used to evaluate ICC biological behavior and prognosis.
Copyright © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Carcinoembryonic antigen; Intrahepatic cholangiocarcinoma; Ki67; Prognosis; Survival; α-fetoprotein

Year:  2020        PMID: 32841741     DOI: 10.1016/j.aohep.2020.07.010

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  6 in total

1.  Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma.

Authors:  Hua Zhao; Benliang Lu
Journal:  Cancer Manag Res       Date:  2022-01-19       Impact factor: 3.989

2.  Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma.

Authors:  Jun Li; Jiongjiong Lu; Shaodong Lv; Xinjun Wang; Xingyang Zhong; Junhua Lu; Shujun Sun; Caifeng Liu; Feng Xu; Haiying Sun; Jiamei Yang
Journal:  BMC Gastroenterol       Date:  2022-05-30       Impact factor: 2.847

Review 3.  Novel approaches in search for biomarkers of cholangiocarcinoma.

Authors:  Lavinia-Patricia Mocan; Maria Ilieș; Carmen Stanca Melincovici; Mihaela Spârchez; Rareș Crăciun; Iuliana Nenu; Adelina Horhat; Cristian Tefas; Zeno Spârchez; Cristina Adela Iuga; Tudor Mocan; Carmen Mihaela Mihu
Journal:  World J Gastroenterol       Date:  2022-04-21       Impact factor: 5.374

4.  A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient.

Authors:  Caterina Peraldo-Neia; Annamaria Massa; Francesca Vita; Marco Basiricò; Chiara Raggi; Paola Bernabei; Paola Ostano; Laura Casorzo; Mara Panero; Francesco Leone; Giuliana Cavalloni; Massimo Aglietta
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

Review 5.  Prognostic and Predictive Molecular Markers in Cholangiocarcinoma.

Authors:  Sandra Pavicevic; Sophie Reichelt; Deniz Uluk; Isabella Lurje; Cornelius Engelmann; Dominik P Modest; Uwe Pelzer; Felix Krenzien; Nathanael Raschzok; Christian Benzing; Igor M Sauer; Sebastian Stintzing; Frank Tacke; Wenzel Schöning; Moritz Schmelzle; Johann Pratschke; Georg Lurje
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

6.  Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection.

Authors:  Qian Li; Yi Wei; Feng Che; Tong Zhang; Shan Yao; Jian Zhao; YuHui Zhang; Hehan Tang; Bin Song
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.